Article Details
Retrieved on: 2021-03-02 12:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... care including high dose steroids (>90%) and remdesivir (>65%); Cerecor has applied for FDA Breakthrough Therapy and Fast Track Designations, ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here